AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

BIOCRYST PHARMACEUTICALS INC Director's Dealing 2012

Jan 23, 2012

31868_dirs_2012-01-23_64393cb8-97cf-4378-8355-5f4c77e48e5c.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2012-01-20

Reporting Person: Hutson Nancy J (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5891	Direct